The device has the ability to monitor intrarenal pressure (IRP) in real-time during kidney stone procedures.

Yu Zheng, MD, and Eric Rovner, MD, physicans in the Department of Urology, Medical University of South Carolina provided an important apprasial of urethral bulking agents for stress urinary incontience in women in a recently published review.

Researchers compared survey responses from patients who had in-person visits and those who used telehealth consultations at Vanderbilt University Medical Center.

"When you plan to retire determines how long you must save for and how long investment returns can compound," writes Jeff Witz, CFP.

Lerapolturev will be given via intravesicular instillation to adult patients with recurrent NMIBC intended for transurethral resection of bladder tumor (TURBT) or cystectomy.

"Over the past 10 to 15 years, tremendous efforts have gone into robotic surgical innovation to improve perioperative morbidity for patients with bladder cancer undergoing RC," write Andrew M. Wood, MD, and Nima Almassi, MD.

The application for darolutamide in the European Union is supported by findings from the phase 3 ARASENS trial.

“If there is such a clear difference between what different physicians are recommending, that calls into the need for patients to be more involved in decisions,” says Angela Fagerlin, PhD.

"I think it's important to realize we're not one-dimensional, that even if we have our day job as urologists, a lot of these things affect us," says Diana Londoño, MD.

Industry expert provides in-depth advice.

"I think what you're going to see is more of the urologic end points, the different cancers, especially prostate cancer," says Mark Moyad, MD, MPH.

"We noted in our overall population, which was about 214 women, there was a 40% discontinuation rate for Botox treatments in the office," says Katherine L. Woodburn, MD.

FACT-RNT is the first tool to measure patient reported outcomes associated with radionuclide therapy for prostate cancer.

The double-blind phase 3 KEYNOTE-991 trial had enrolled 1251 patients.

"The different outcomes in [these] cases highlight the contextual nature of medical care," writes Kenton H. Steele, Esq.

The spray is a liquid suspension of sildenafil citrate administered orally via a spray pump.

The phase 2 Cyto-KIK study is exploring cytoreductive surgery plus immunotherapy with nivolumab and targeted kinase inhibition with cabozantinib in metastatic kidney cancer.

The study considered 4 dimensions of the workplace: equal access, work-life balance, freedom from gender bias, and supportive leadership.

In this interview, Ira Sharlip, MD, explains the potential dangers these products pose and what urologists can do to help protect their patients.

"Last year was a year of many changes socially within the United States. Some of those changes stirred up a lot of interest, enthusiasm, and energy for trying to direct our community toward positive change," said Manoj Monga, MD, FACS.

Patient data is so valuable — and smaller providers are more vulnerable — that hackers are increasingly targeting physician groups.

BCAN’s Young Investigator Awards support outstanding early-career scientists and clinical cancer researchers with a demonstrated commitment to improving the understanding and treatment of bladder cancer and/or upper tract urothelial cancer.

"Patients with intermediate-risk NMIBC remain an incredibly heterogeneous group," says Wei Shen Tan, MD, PhD.

An associate professor of Urology at Yale School of Medicine, Dr. Kenney specializes in treating genitourinary cancers, with a particular focus on kidney cancers.

"Digital engagement technology, which can be seamlessly integrated into a health system or hospital's existing processes," writes Chelsea King Arthur.